Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 4INTERVENTIONAL

HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men

HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women. A Randomized, Placebo-Controlled, Double-Blind Parallel Trial.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Randomized clinical trial evaluating the effect of acetazolamide on sleep disordered breathing in women compared to men travelling to 3600 m.

Who May Be Eligible (Plain English)

Who May Qualify: - Healthy, non-smoking men and women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives). - BMI \>18 kg/m2 and \<30 kg/m2 - Born, raised and currently living at altitudes \<1000 m - Written willing to sign a consent form - Premenopausal women with an eumenorrheic cycle Who Should NOT Join This Trial: - Other types of contraceptvies (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others) - Pregnancy or nursing - Anaemic (haemoglobin concentration \<10g/dl) - Any altitude trip \<4 weks before the study - Allergy to acetazolamide and other sulfonamides Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Healthy, non-smoking men and women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives). * BMI \>18 kg/m2 and \<30 kg/m2 * Born, raised and currently living at altitudes \<1000 m * Written informed consent * Premenopausal women with an eumenorrheic cycle Exclusion Criteria: * Other types of contraceptvies (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others) * Pregnancy or nursing * Anaemic (haemoglobin concentration \<10g/dl) * Any altitude trip \<4 weks before the study * Allergy to acetazolamide and other sulfonamides

Treatments Being Tested

DRUG

Acetazolamide

Administration of 1x125mg acetazolamide in the morning, 1x125mg in the evening, starting 24 hours before departure to 3600 m.

DRUG

Placebo

Administration of equally looking placebo capsules in the morning and in the evening, starting 24 hours before departure to 3600 m.

Locations (1)

National Center for Cardiology and Internal Medicine
Bishkek, Gorod Bishkek, Kyrgyzstan